SLNSW-Neoadjuvant plus adjuvant or only adjuvant nab-pa...-TN_cdi_doaj_primary_oai_doaj_org_article_4b8d6fac7cb54c6aaa9dcd06f710f790

Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group

Full title: Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group

Author/creator: Ettrich, Thomas J, Berger, Andreas W, Perkhofer, Lukas, Daum, Severin, König, Alexander, Dickhut, Andreas, Wittel, Uwe, Wille, Kai, Geissler, Michael, Algül, Hana, Gallmeier, Eike, Atzpodien, Jens, Kornmann, Marko, Muche, Rainer, Prasnikar, Nicole, Tannapfel, Andrea, Reinacher-Schick, Anke, Uhl, Waldemar, Seufferlein, Thomas.

Call Numbers:

Record Identifier: TN_cdi_doaj_primary_oai_doaj_org_article_4b8d6fac7cb54c6aaa9dcd06f710f790

Language: English

Formats: Articles

Publishers: England: BioMed Central Ltd

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4b8d6fac7cb54c6aaa9dcd06f710f790

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group

    Record identifier

    TN_cdi_doaj_primary_oai_doaj_org_article_4b8d6fac7cb54c6aaa9dcd06f710f790

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4b8d6fac7cb54c6aaa9dcd06f710f790

    Share

    Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4b8d6fac7cb54c6aaa9dcd06f710f790

    Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group

    Full title

    Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group

    Author / Creator

    Ettrich, Thomas J ; Berger, Andreas W ; Perkhofer, Lukas ; Daum, Severin ; König, Alexander ; Dickhut, Andreas ; Wittel, Uwe ; Wille, Kai ; Geissler, Michael ; Algül, Hana ; Gallmeier, Eike ; Atzpodien, Jens ; Kornmann, Marko ; Muche, Rainer ; Prasnikar, Nicole ; Tannapfel, Andrea ; Reinacher-Schick, Anke ; Uhl, Waldemar ; Seufferlein, Thomas

    Publisher

    England: BioMed Central Ltd

    Journal title

    BMC cancer, 2018, Vol.18 (1), p.1298-10

    Record Identifier

    TN_cdi_doaj_primary_oai_doaj_org_article_4b8d6fac7cb54c6aaa9dcd06f710f790

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Adenocarcinoma Adult Aged Albumins - therapeutic use Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cancer Cancer therapies Carcinoma, Pancreatic Ductal - mortality Carcinoma, Pancreatic Ductal - therapy Chemotherapy Clinical trials Clinical Trials, Phase II as Topic Deoxycytidine - analogs & derivatives Deoxycytidine - therapeutic use Deoxyribonucleic acid Disease Progression Disease-Free Survival DNA Dosage and administration Drug Combinations Drug therapy Fluorouracil - therapeutic use Gemcitabine Gene expression Germany - epidemiology Humans Leucovorin - therapeutic use Lymph nodes Medical prognosis Metastases Metastasis Middle Aged miRNA Multicenter Studies as Topic Neoadjuvant chemotherapy Neoadjuvant Therapy - methods Organometallic Compounds - therapeutic use Paclitaxel Paclitaxel - therapeutic use Pancreatectomy Pancreatic cancer Pancreatic ductal adenocarcinoma Pancreatic Neoplasms - mortality Pancreatic Neoplasms - therapy Patient outcomes Patients Perioperative chemotherapy Pharmacogenomics Prognosis Prospective Studies Quality of Life Questionnaires Randomized Controlled Trials as Topic Resectable Risk factors Studies Study Protocol Surgery Survival Survival Analysis Toxicity Tumors Young Adult

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_doaj_primary_oai_doaj_org_article_4b8d6fac7cb54c6aaa9dcd06f710f790

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4b8d6fac7cb54c6aaa9dcd06f710f790

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections